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ABSTRACT 
 
Bacground: Atrial fibrillation (AF) patients are 5 times more likely to have stroke than non-AF 
patients. Stroke prevention (SP) using anticoagulation therapy was recommended in AF 
patients. Knowledge about AF and SP (KAFSP) is one of the essential factors that can improve 
patients’ adherence. Yet no established studies were found to determine patients’ KAFSP 
among AF patients. Objectives: To develop and validate the questionnaire used to measure 
KAFSP. Methods: A cross-sectional survey was conducted in 4 hospitals in Malaysia. The 
psychometric of the KAFSP Questionnaire (KAFSP-Q) were performed using content validity 
index (CVI), internal consistency, test-retest, exploratory factor analysis (EFA), and sensitivity 
test. Results: A total of 304 patients completed a face-to-face interview to answer the KAFSP-Q. 
Content and face validity was assessed by 6 experts who are knowledgeable in this field and 15 
AF patients, respectively. The KAFSP-Q had good CVI and were well understood by AF patients. 
The KAFSP-Q also had good reliability and stability with Cronbach’s α of .83 and intraclass 
correlation coefficient values in test-retest for stability of .9. The EFA results indicated that 
there were 6 factors with factor loadings above .30. The low correlations between subscales 
ranged between .01 and .48, which indicated that good discriminant and construct validity were 
achieved. The scale was able to differentiate between patients’ knowledge levels before and 
after counseling given. Conclusions: The KAFSP-Q is reliable and valid to measure patients’ 
KAFSP. Further validation studies are recommended to validate the KAFSP-Q in different 
contexts and in other languages. 
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